Similarly, significant downregulation of GRK2 and GRK6 expression has been observed in peripheral blood mononuclear cells (PBMCs) from patients with rheumatoid arthritis (RA) or multiple sclerosis (MS)52–54. This evidence concerns the gene GRK2 and myeloid sarcoma.